Submitting Clinical Trial

December 04, 2024

ENDO is a fantastic venue for your clinical trial research!

Highlight your ongoing and future clinical trials in the field of Endocrinology, Diabetes, Obesity, and Metabolism, by submitting a Clinical Trial abstract to ENDO, the Endocrine Society’s Annual Meeting. Showcase your work, recruit participants, and drive engagement at the world’s largest gathering of endocrinologists.

Benefits of presenting at ENDO include:

  • Peer review by top scientists in endocrinology, diabetes, obesity, and metabolism
  • Exposure at the world’s largest gathering of scientists, endocrinologists, and endocrine subspecialists
  • Ability to advertise open recruitments

PRELIMINARY DATA IS WELCOME

The Society understands that limited data may be available at the time of the submission deadline. The abstract submission should detail the trial design and rationale, inclusion criteria, primary clinical endpoints, and any available preliminary data. Lead investigators are still encouraged to submit if additional data is anticipated to be available for presentation by the first day of ENDO.

SUBMISSION OPTIONS

Authors may opt to embargo the publication of their abstract until the date of presentation.

SUBMISSION QUESTIONS?

  • For additional details on the ENDO abstract submission process, please visit ENDO 2025.
  • If you have any additional questions concerning the process for submitting a Clinical Trial abstract, please contact [email protected].
Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.